Development of the ATAQ-IPF: a tool to assess quality of life in IPF
about
Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosisIPF clinical trial design and endpointsA mixed-methods study of the Care Needs of individuals with idiopathic Pulmonary fibrosis and their carers--CaNoPy: a study protocol.Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA)The need for patient-centred clinical research in idiopathic pulmonary fibrosisPatient-reported outcomes in idiopathic pulmonary fibrosis researchContent validity of CASA-Q cough domains and UCSD-SOBQ for use in patients with Idiopathic Pulmonary FibrosisOutcome Measures for Clinical Trials in Interstitial Lung Diseases.Clinical trials and tribulations--lessons from pulmonary fibrosis.Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature.Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?Symptom-based management of the idiopathic interstitial pneumonia.Optimizing quality of life in patients with idiopathic pulmonary fibrosis.New treatment directions for IPF: current status of ongoing and upcoming clinical trials.The COPD Assessment Test as a Prognostic Marker in Interstitial Lung Disease.Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.Patient-reported outcome measures in idiopathic pulmonary fibrosis: Where do we stand?The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations.Psychometric properties of the St George's Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trials.Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives
P2860
Q26747694-57AFF2AA-1232-43ED-8607-AD7E9CF0A0D3Q26995648-B5F1636D-2D41-4711-8CFA-02F1FBCBD7F2Q30542598-8A952DBF-FAE9-4CBA-B2A8-80FD6D410640Q34419914-3C0F4449-F636-4405-9225-B5D08F5D9553Q35785546-A1333AE8-08C8-411D-9B53-8940658BC0BBQ36182189-C9F936C2-420B-4AC9-891F-EAE2DCD8B1BCQ36647810-C3E34BD2-89CA-4607-9865-6AAA7A15DF62Q36726418-98ACDF02-B408-4EB3-9E1F-9D4EE218B8AEQ36896973-BD959910-7249-4EED-8FF4-B80E42898F09Q38064381-DD6A4624-6C6D-4DB8-B0BC-E333FFA8BCBCQ38233856-2B9C31E3-47CE-4E83-A567-045A5ED22316Q38602725-CB7ED476-B4EB-4322-9A3E-88A8E7CA9035Q39108878-70571E7F-48F4-4C46-B597-12FFC5EA1AFAQ39330304-3FC42340-0A69-4E10-8A02-96463EF13E35Q41642420-33F7EA26-58D6-40B6-A7C7-72976313E046Q47101057-E8EFD1CA-B257-4F1A-8DE7-B062A297BA36Q47942905-1A564AFE-218D-4B12-A722-ED66318301EDQ51410723-F244BC4B-73CA-4D99-969B-6EDA4F74229DQ51763710-6C0FDEEF-6D79-41D1-8AD1-60A98F9CE738Q55021513-E8D0405E-9BAD-4449-AD8F-F6523F5CF23EQ57071456-40C6F1DE-06DE-425B-8903-C7E9CBE02C39
P2860
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
@ast
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
@en
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
@nl
type
label
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
@ast
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
@en
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
@nl
prefLabel
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
@ast
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
@en
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
@nl
P2093
P2860
P356
P1476
Development of the ATAQ-IPF: a tool to assess quality of life in IPF
@en
P2093
David B Sprunger
Frederick S Wamboldt
Jeffrey J Swigris
Kathy E Green
Kevin K Brown
Sandra R Wilson
P2860
P2888
P356
10.1186/1477-7525-8-77
P577
2010-07-31T00:00:00Z
P5875
P6179
1023694296